Short-term administration of growth hormone (GH) lowers blood pressure by activating eNOS/nitric oxide (NO)-pathway in male hypophysectomized (Hx) rats

BMC Physiology

Volumn 5, Issue , 2005, Pages

  Nyström, Henrik C ^a   Klintland, Natalia ^b   Caidahl, Kenneth ^b   Bergström, Göran ^a,b   Wickman, Anna ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOCORTICOID; GROWTH HORMONE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; THYROXINE; ENZYME INHIBITOR; NITRIC ACID DERIVATIVE; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BLOOD FLOW; BLOOD LEVEL; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM LESION; ENZYME ACTIVATION; HEART RATE; HYPOPHYSECTOMY; IN VIVO STUDY; MALE; NONHUMAN; PRESSORECEPTOR; PROTEIN EXPRESSION; RAT; TELEMETRY; URINE LEVEL; VASCULAR RESISTANCE; ANATOMY AND HISTOLOGY; ANIMAL; BLOOD; BLOOD PRESSURE; BLOOD VESSEL; BODY WEIGHT; DRUG ADMINISTRATION; DRUG EFFECTS; HEART; METABOLISM; ORGAN SIZE; PHYSIOLOGY; SKELETAL MUSCLE; URINE; VASCULARIZATION; WISTAR RAT;

ANIMALS; BLOOD PRESSURE; BLOOD VESSELS; BODY WEIGHT; DRUG ADMINISTRATION SCHEDULE; ENZYME ACTIVATION; ENZYME INHIBITORS; GROWTH HORMONE; HEART; HEART RATE; HYPOPHYSECTOMY; INSULIN-LIKE GROWTH FACTOR I; MALE; MUSCLE, SKELETAL; NG-NITROARGININE METHYL ESTER; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; ORGAN SIZE; PRESSORECEPTORS; RATS; RATS, WISTAR; VASCULAR RESISTANCE;

EID: 28444453287     PISSN: 14726793     EISSN: 14726793     Source Type: Journal    
DOI: 10.1186/1472-6793-5-17     Document Type: Article

References (27)

1. Capaldo B, Guardasole V, Pardo F, Matarazzo M, Di Rella F, Numis F, Merola B, Longobardi S, Sacca L: Abnormal vascular reactivity in growth hormone deficiency. Circulation 2001, 103:520-524.
2. Böger RH, Skamira C, Bode-Böger SM, Brabant G, von zur Muhlen A: Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. J Clin Invest 1996, 98:2706-2713.
3. Khan AS, Sane DS, Wannenburg T, Sonntag WE: Growth hormone, insulin-like growth factor-1 and the aging cardiovascular system. Cardiovasc Res 2002, 54:25-35.
4. McCallum RW, Petrie JR, Dominiczak A, Connell MC: Growth hormone deficiency and vascular risk. Clin Endocrinol 2002, 57:11-24.
5. Saccá L, Cittadini A, Fazio S: Growth hormone and the heart. Endocrine Reviews 1994, 15:555-573.
6. Caidahl K, Edén S, Bengtsson B: Cardiovascular and renal effects of growth hormone. Clin Endocrinol (Oxf) 1994, 40(3):393-400.
7. Evans LM, Davies JS, Anderson RA, Ellis GR, Jackson SK, Lewis MJ, Frenneaux MP, Rees A, Scanlon MF: The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency. Eur J Endocrinol 2000, 142:254-262.
8. László FA, Csernay L, Kocsis J: Effects of hypophysectomy on haemodynamic changes induced by administration of oestrone + vasopressin. Res exp Med 1974, 163:219-227.
9. Shen YT, Wiedmann RT, Lynch JJ, Grossman W, Johnson RG: GH replacement fails to improve ventricular function in hypophysectomized rats with myocardial infarction. Am J Physiol 1996, 271:H1721-H1727.
10. Gustafsson H, Wickman Tordby A, Brandin L, Hedin L, Jonsdottir IH: The interactive effects of growth hormone and oestrogen on vascular responses in hypophysectomized female rats. Eur J Endo 2002, 146:267-274.
11. Rossoni G, Locatelli V, De GCV, Torsello A, Schweiger F, Boghen M, Nilsson M, Bernareggi M, Muller EE, Berti F: Growth hormone and hexarelin prevent endothelial vasodilator dysfunction in aortic rings of the hypophysectomized rat. J Cardiovasc Pharmacol 1999, 34:454-460.
12. Wickman A, Jonsdottir IH, Bergstrom G, Hedin L: GH and IGF-I regulate the expression of endothelial nitric oxide synthase (eNOS) in cardiovascular tissues of hypophysectomized female rats. Eur J Endocrinol 2002, 147:523-533.
13. Folkow B, Isaksson OGP, Karlström G, Lever AF, Nordlander M: Trophic effects of hypophyseal hormones on resistance vessels and the heart in normotensive and renal hypertensive rats. Acta Physiologica Scandinavica 1992, 144:291-306.
14. Napoli R, Guardasole V, Angelini V, D'Amico F, Zarra E, Matarazzo M, Sacca L: Acute effects of growth hormone on vascular function in human subjects. J Clin Endocrinol Metab 2003, 88:2817-2820.
15. Thum T, Tsikas D, Frölich JC, Borlak J: Growth hormone induces eNOS expression and nitric oxide release in a cultured human endothelial cell line. FEBS Letters 2003, 555:567-571.
16. Honeyman TW, Goodman HM, Fray JCS: The effects of growth hormone on blood pressure and renin secretion in hypophysectomized rats. Endocrinology 1983, 112:1613-1617.
17. Moller J, Jorgensen JO, Moller N, Hansen KW, Pedersen EB, Christiansen JS: Expansion of extracellular volume and suppression of atrial natriuretic peptide after growth hormone administration in normal man. J Clin Endocrinol Metab 1991, 72:768-772.
18. Hoffman DM, Crampton L, Sernia C, Nguyen TV, Ho KKY: Short-term growth hormone (GH) treatment of GH-deficient adults increases body sodium and extracellular water, but not blood pressure. J Clin Endocrinol Metab 1996, 81:1123-1128.
19. Bohlooy-Y M, Carlsson L, Olsson B, Gustafsson H, Andersson IJL, Törnell J, Bergström G: Vascular function and blood pressure in growth hormone transgenenic mice. Endocrinology 2001, 142:3317-3323.
20. Dilley RJ, Schwartz SM: Vascular remodeling in the growth hormone transgenic mouse. Circulation Research 1989, 65:1233-1240.
21. Fielder PJ, Mortensen DL, Mallet P, Carlsson B, Baxter RC, Clark R: Differential long-term effects of insulin-like growth factor-I (IGF-I), growth hormone (GH), and IGF-I plus GH on body growth and IGF-I binding proteins in hypophysectomized rats. Endocrinology 1996, 137:1913-1920.
22. Sakuma I, Togashi H, Yoshioka M, Saito H, Yanagida M, Tamura M, Kobayashi T, Yasuda H, Gross SS, Levi R: NG-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. A role for nitric oxide in the central regulation of sympathetic tone? Circ Res 1992, 70:607-611.
23. Sverrisdottir YB, Elam M, Herlitz H, Bengtsson BA, Johannsson G: Intense sympathetic nerve activity in adults with hypopituitarism and untreated growth hormone deficiency. J Clin Endocrinol Metab 1998, 83:1881-1885.
24. Leong KS, Mann P, Wallymahmed M, MacFarlane IA, Wilding JP: Influence of growth hormone replacement on heart rate variability in adults with growth hormone deficiency. Clin Endocrinol 2001, 54:819-826.
25. Evans LM, Davies JS, Goodfellow J, Rees JA, Scanlon MF: Endothelial dysfunction in hypopituitary adults with growth hormone deficiency. Clin Endocrinol (Oxf) 1999, 50:457-464.
26. Jayachandran M, Hayashi T, Sumi D, Thakur NK, Kano H, Ignarro LJ, Iguchi A: Up-regulation of endothelial nitric oxide synthase through beta(2)- adrenergic receptor - the role of a betablocker with NO-releasing action. Biochem Biophys Res Commun 2001, 280:589-594.
27. Wennmalm A, Benthin G, Edlund A, Jungersten L, Kieler-Jensen N, Lundin S, Westfelt UN, Petersson AS, Waagstein F: Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ Res 1993, 73:1121-1127.